Meta-Analysis Open Access
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3568-3577
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3568
Outcome and risk factors of ulcer healing after gastric endoscopic submucosal dissection: A systematic review and meta-analysis
De-Yi Chen, Dan Jiang, Yu Li, Bing Han, Li-Chun Han, Xiao-Fang Xu, Shi-Quan Li, Guang-Fu Lin, Zhi-Xi Huang, Jia-Ning Lin, Xiao-Ping Lv, Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Hai-Dong Chen, Department of Gastroenterology, The Tenth Affiliated Hospital of Guangxi Medical University, Qinzhou 535000, Guangxi Zhuang Autonomous Region, China
Xiao-Dan Lv, Department of Clinical Experimental Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Zhou Huang, Department of Emergency, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
ORCID number: Bing Han (0000-0001-7600-6693); Shi-Quan Li (0000-0003-3744-2737); Xiao-Ping Lv (0000-0001-7144-9508).
Author contributions: Chen DY and Chen HD conducted a literature research and search, developed a methodology, collected data, performed statistical analysis and quality evaluation, evaluated the results, and wrote the manuscript; Lv XD, Huang Z and Jiang D conducted a literature search, gathered data, performed statistical analysis, and evaluated the product’s quality; Li Y and Han B analyzed the information, made important recommendations, and edited the paper; Li SQ, Han LC, and Xu XF examined the information and made important recommendations; Lin JN, Huang ZX, and Lin GF looked over the information; Lv XP designed the project, created the procedure, performed the statistical analysis, evaluated the outcome, looked over the information, and reviewed the paper.
Supported by the National Natural Science Foundation of China, No. 81860104; the Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation, No. 2023GXNSFDA026024; the Development and Application of Medical and Health Appropriate Technology Project in Guangxi Zhuang Autonomous Region, No. S2018049; the Self-financing Project of Health Commission of Guangxi Zhuang Autonomous Region, No. Z20200398; and the Innovation Project of Guangxi Graduate Education, No. YCBZ2022079.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiao-Ping Lv, MD, Chief Physician, Professor, Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. lxxp58@hotmail.com
Received: July 1, 2024
Revised: September 1, 2024
Accepted: September 29, 2024
Published online: November 27, 2024
Processing time: 121 Days and 2.6 Hours

Abstract
BACKGROUND

Endoscopic submucosal dissection (ESD) is widely utilized for the treatment of large adenomas, submucosal lesions, and early gastric cancer. A significant artificial ulcer typically forms after ESD. Delayed or incomplete healing of these ulcers can result in complications such as delayed bleeding and perforation. However, a comprehensive review of the outcomes and risk factors related to ulcer healing following ESD is currently lacking.

AIM

To assess ulcer healing outcomes and identify risk factors associated with delayed ulcer healing.

METHODS

Databases retrieved by computer include PubMed, EMBASE, The Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wan Fang Data, and VIP. The study collects reports on ESD post-surgical ulcer healing outcomes and risk factors, using Stata 16.0 and RevMan 5.0 software for meta-analysis.

RESULTS

Our analysis included 12 studies, involving a total of 3430 patients. The meta-analysis revealed an overall healing rate of 65.55% for ulcers following ESD [odds ratio (OR) = 2.71; 95% confidence interval (CI): 2.45-3.00]. The healing rate within eight weeks was 48.32% (OR = 0.76; 95%CI: 0.35-1.66), while the rate beyond eight weeks was 88.32% (OR = 6.73; 95%CI: 3.82-11.87). Risk factors included Helicobacter pylori (H. pylori) infection (OR: = 5.32; 95%CI: 1.90-14.87; P = 0.001), ulcer size (OR = 2.08; 95%CI: 1.19-3.61; P = 0.01), lesion site (OR = 2.08; 95%CI: 1.19-3.11), and pathological type (OR = 1.64; 95%CI: 1.06-2.52). Diabetes (OR = 0.56; 95%CI: 0.05-5.80; P = 0.63) and duration of operation (OR = 1.00; 95%CI: 0.99-1.01; P = 0.96) were not significant factors.

CONCLUSION

The healing rate of ulcers following ESD is high after eight weeks. Risk factors affecting the healing process include H. pylori infection, ulcer size, lesion site, and pathological type.

Key Words: Endoscopic submucosal dissection; Gastric ulcer; Artificial ulcer; Outcome; Risk factors; Systematic review; Meta-analysis

Core Tip: The factors influencing the healing of artificial ulcers created by endoscopic submucosal dissection (ESD) remain unclear. This study examines ulcer healing outcomes and the risks associated with delayed healing. The healing rate of ulcers following ESD is high after eight weeks. Treatment for eight weeks or longer may support complete ulcer healing. A meta-analysis of risk factors, based on multivariate regression analysis, indicates that ulcer size, lesion site, Helicobacter pylori infection, and pathological type are key variables affecting the healing process, while diabetes and the duration of the operation do not have a significant impact.



INTRODUCTION

The endoscopic resection technique known as endoscopic submucosal dissection (ESD) was initially developed in the late 1990s and early 2000s[1]. ESD has been widely employed for large adenomas, submucosal lesions, and early stomach cancer due to ongoing research and procedural refinements[2,3]. This method allows for the complete removal of the lesion, increasing the resection rate. In general, ESD technology is effective and safe. However, complications such as bleeding and perforation can occur when lesions are excised with ESD. Unlike traditional ulcer formation mechanisms in the clinic, a significant artificial ulcer usually forms post-procedure. The risk of bleeding and perforation increases when these ulcers take longer to heal[4-6]. While it has been proposed that all artificial ulcers created by electrosurgical drainage (ESD) will heal within 8 weeks[7], recent research indicates that 5%-20% of individuals with post-ESD ulcers do not heal within this timeframe[8,9]. Consequently, further research on ESD ulcers and their healing is needed, as well as the development of a treatment plan for ESD ulcers. Relevant studies have investigated and examined the factors contributing to the slower healing of artificial ulcers after ESD[2,5,10-12]. However, the results obtained are inconsistent or conflicting due to varying standards across studies. It remains unclear what influences the healing of artificial ulcers created by ESD. Currently, there is no published systematic review or meta-analysis on the ulcer healing rate or the risk factors for delayed ulcer healing following endoscopic therapy. Our goals are to perform a meta-analysis to gain a thorough understanding of the ulcer healing rate, identify common risk factors for delayed ulcer healing, and provide clinicians with a foundation for management and treatment.

MATERIALS AND METHODS

This systematic review and meta-analysis adhered to the standards set forth by the preferred reporting items for systematic reviews and meta-analyses[13] and the meta-analysis of observational studies in epidemiology[14]. Additionally, the study was registered with the international prospective register of systematic reviews under the registration number No. CRD42024543288.

Literature sources and search strategy

The following search terms were utilized: (“ulcer” OR “scar” OR “mucosal healing” OR “ulcer healing”), (“endoscopic submucosal dissection” OR “ESD”), and (“risk factors” OR “influence factor”). We searched MEDLINE via PubMed, Web of Science, EMBASE, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wan-fang database, and VIP database from the inception until April 17, 2024. All of the search terms used in each database are shown in Supplementary Table 1.

Inclusion and exclusion criteria

Studies were selected for inclusion based on the following criteria: (1) Study population: Individuals with post-ESD; (2) Outcome indicators: Ulcer healing rate and/or risk factors after ESD; and (3) Multivariate regression analysis of risk factors. The following studies were excluded: (1) The ulcer healing indicator is not in the scarring stage (S stage); (2) Duplicate publication, conference abstracts, reviews, comments; (3) Data missing or univariate analysis or not available odds ratio (OR), 95% confidence intervals (CIs) or not transformable raw data; (4) Theses and case reports; (5) Animal studies; and (6) Non-English or non-Chinese articles.

Data extraction and quality assessment

Various categories of data were extracted from all included studies: Study characteristics such as the first author’s name, publication year, country of origin, study design, and sample size. Outcome indicators: Ulcer healing rate, risk factors with prolonged ulcer healing, OR, and 95%CIs. The Cochrane Collaboration’s tool was employed to evaluate the quality of randomized controlled trials (RCTs) and their post hoc analyses. The Newcastle-Ottawa scale checklist[15] was used to assess the quality of case-control and cohort studies. Every item on this checklist was given a score of either 0 or 1. The classifications for low, medium, and high quality were 0-5, 6-7, and 8-9, respectively. The publications that satisfied the minimum score requirement of 7 to be considered for the meta-analysis process were incorporated into the data extraction and meta-analysis procedure. Two researchers conducted independent data extraction and assessed the quality of the eligible studies. Any disagreements were addressed through by consensus, with a third researcher resolving any further disagreements to reach a conclusion.

Evaluation criteria for ulcer healing

A six-stage framework was employed to categorize the phases of gastric ulcers: (1) A1 stage: Characterized by a mucus-coated ulcer exhibiting mild elevation due to edema; (2) A2 stage: Ulcer with diminished edema, still coated in mucus, and displaying more defined borders in comparison to the A1 stage; (3) H1 stage: Open wound with less than 50% epithelial regeneration, which may or may not feature converging folds; (4) H2 stage: An ulcer presenting a mucosal breach, predominantly covered by regenerating epithelium; (5) S1 stage: Absence of a mucosal break, revealing a red scar with irregular epithelialization; and (6) S2 stage: Complete re-epithelialization accompanied by the presence of a white scar. The process of ulcer healing was delineated through the scarring stages as per the Sakita-Fukutomi classification system[16-19]. The healing stage or ulcer shrinkage indicated that the ulcer had not yet achieved complete healing.

Statistical analysis

Data analyses were executed utilizing review manager 5.4 (Cochrane Collaboration, Oxford, United Kingdom) and STATA (version 15, Stata Corp LLC, College Station, TX, United States) for the meta-analysis encompassing all selected studies. An initial heterogeneity analysis was conducted on the included articles. If the results indicated I² value of less than 50%, a fixed effect model was employed for the meta-analysis; conversely, a random effect model was utilized. OR and 95%CIs were computed, and sensitivity analyses were performed to assess the stability of the findings. A P value of < 0.05 was considered statistically significant.

RESULTS
Study selection and characteristics

A sum of 2631 articles was collected: 454 from PubMed, 1172 from EMBASE, 445 from Web of Science, 92 from Cochrane Library, 154 from CNKI, 305 from Wan-fang database, and 9 from VIP database. After removing duplicates, the titles and abstracts of 2085 papers were screened, and 13 studies met our inclusion criteria. One study was excluded due to incorrect 95%CI data, leaving 12 full-text studies[9,16,18,20-28] for the meta-analysis. Figure 1 illustrates the flowchart outlining the search and selection process. Among the 12 included publications, 7 were cohort studies, 3 were case-control studies, 4 were RCTs, and 1 was mixed (cohort + RCT). All studies demonstrated a medium to high level of quality and collectively included a total of 3430 participants. Six risk factors were incorporated in the multifactorial regression analysis, with data extraction from at least two publications mentioning the same risk factor: (1) Helicobacter pylori (H. pylori) infection; (2) Ulcer size; (3) Lesion site; (4) Diabetes; (5) Pathology of the lesion; and (6) Duration of operation. The fundamental characteristics of the included studies are presented in Table 1, while the quality assessment is detailed in Supplementary Table 2 and Supplementary Table 3, as well as Supplementary Figure 1.

Figure 1
Figure 1  Flowchart of the search and selection process.
Table 1 Study selection and characteristics.
Ref.
Country
Total (n)
Study type
Outcomes: Ulcer healing rate
Risk factor
< 8 weeks (%)
≥ 8weeks (%)
Gong et al[20]China196Prospective cohort79.59-2
Fei et al[21]China200Case control78.40-1,2,3
Huang et al[22]China112Case control--3,4
Kobayashi et al[18]Japan170Randomized controlled study17.10-2
Lee et al[23]Korea192Retrospective cohort61.880.52
95Randomized controlled study42.683.3
Lim et al[9]Korea1680Retrospective cohort-94.32,4,5
Nakamura et al[16]Korea109Randomized controlled study13.884.42,3,5
Otsuka et al[24]Japan132Prospective cohort-92.11,2,3,6
Shimozato et al[25]Japan73Retrospective cohort-78.12,3,6
Shen et al[26]China152Prospective cohort69.09-2,3,5,6
Shao et al[27]China152Case control-78.11
Yamasaki et al[28]Japan167Retrospective cohort24.5-2,3
Outcome of ulcer healing

The ulcer healing rate was used to determine the ulcer healing outcome. The pooled analysis revealed a total ulcer healing rate of 65.55 percent; the heterogeneity test showed (P < 0.00001; I2 = 98%). A sensitivity analysis was performed by sequentially excluding individual studies and re-evaluating the remaining studies to determine if the findings could have been substantially influenced by any single study. The results indicated that heterogeneity remained consistent throughout the sensitivity analysis. A meta-analysis was performed utilizing the random effects model. P > 0.05, no statistical significance, (OR = 2.71; 95%CI: 2.45-3.00; P > 0.05), no statistical significance, Supplementary Figure 2A. Subgroup analysis included one subgroup < 8 weeks and another subgroup ≥ 8 weeks. The ulcer healing rate was 48.32% for the subgroup < 8 weeks, (OR = 0.76; 95%CI: 0.35-1.66; P > 0.05), Supplementary Figure 2B; for ≥ 8 weeks, the ulcer healing rate was 88.34%, (OR = 6.73; 95%CI: 3.82-11.87; P < 0.00001), Supplementary Figure 2C. The results showed a statistically significant variation in the rate of ulcer healing postoperatively, as assessed over an 8-week period (Table 2).

Table 2 Outcome of ulcer healing during different time periods.
Different durations
Studies
Patients (n)
OR
95%CI
P value
Heterogeneity
χ2
df
P value
I2 (%)
Overall1137192.712.45-3.000.06808.1114< 0.0000198
< 8 weeks712860.760.23-0.460.49188.647< 0.0000196
≥ 8 weeks624336.733.82-11.87< 0.0000174.586< 0.0000192
Risk factors

H. pylori infection: Three articles[21,24,27] reported the impact of H. pylori infection on the healing of ulcers following ESD. The test for heterogeneity showed (P = 0.005; I2 = 81%). Subsequent analysis indicated that the primary contributor to heterogeneity was the study conducted by Fei et al[21], which featured a follow-up duration of less than 8 weeks. Except for this particular study, the other studies exhibited no significant statistical heterogeneity (P = 0.30; I2 = 8%). Meta-analysis conducted utilizing a fixed-effects model indicated that H. pylori infection was a significant risk factor for ulcer healing, with an OR = 5.32, 95%CI: 1.90-14.87, P = 0.001 (Figure 2A).

Figure 2
Figure 2 Helicobacter pylori forest plots of various risk factors. A: Helicobacter pylori infection; B: Ulcer size; C: Lesion site; D: Pathology of lesion; E: Diabetes; F: Duration of operation. CI: Confidence interval.

Ulcer size: Ten articles[9,16,18,20,21,23-26,28] examined the impact of ulcer size on the healing process following ESD. The test for heterogeneity showed (P < 0.00001; I2 = 92%). Using sensitivity analysis, the heterogeneity remained unchanged. Meta-analysis employing a random-effects model revealed that the size of the ulcer serves as a significant risk factor for the healing of ulcers postoperatively, with an OR = 1.13, 95%CI: 1.02-1.26, P = 0.02 (Figure 2B).

Lesion site: Seven articles[16,21,22,24-26,28] reported the effect of ulcer location (specifically, ulcers situated in the distal third of the stomach) on postoperative ulcer healing. The test for heterogeneity showed (P = 0.004; I2 = 69%). Sensitivity analysis identified the study by Yamasaki et al[28], which had a follow-up period of 4 weeks and clinical selection bias, as the source of heterogeneity. Except for this study, no significant statistical heterogeneity was detected (P = 0.23; I2 = 27%). Meta-analysis conducted utilizing a fixed-effects model indicated that ulcer location was a risk factor for postoperative ulcer healing, with an OR = 2.08, 95%CI: 1.19-3.61, P = 0.01 (Figure 2C).

Pathology of lesion: Three articles [9,16,26] examined the influence of the pathological characteristics of ulcer sites on the healing process following surgery. The test for heterogeneity showed (P = 0.18; I2 = 42%). Meta-analysis conducted using a fixed-effects model indicated that the pathology of the ulcer was a significant risk factor for postoperative healing, with an OR = 1.64, 95%CI: 1.06-2.52, P = 0.03 (Figure 2D).

Diabetes: Two articles[9,22] reported the effect of diabetes mellitus on postoperative ulcer healing. The test for heterogeneity showed (P = 0.0003; I2 = 92%). Meta-analysis was conducted utilizing a random effects model, which revealed that diabetes mellitus does not serve as a risk factor for the healing of postoperative ulcers, with an OR = 0.56, 95%CI: 0.05-5.80, P = 0.63 (Figure 2E).

Duration of operation: Three articles[24-26] examined the impact of surgical duration on the healing of postoperative ulcers. The test for heterogeneity showed (P = 0.27; I2 = 23%). Meta-analysis was conducted utilizing a fixed-effect model, which demonstrated that the length of surgical procedures did not serve as a risk factor for the healing of postoperative ulcers, with an OR = 1.00, 95%CI: 0.99-1.01, P = 0.96 (Figure 2F).

Bias assessment

Using the effect indicator (OR) as the horizontal axis and the standard error as the vertical axis, a bias funnel plot was drawn (see Supplementary Figure 3). Except for the risk factors H. pylori infection and diabetes, which were included in fewer studies, making the Egger test unable to provide further bias evaluation, the remaining studies did not exhibit publication bias Table 3.

Table 3 Bias assessment: Egger's test.

Outcome of ulcer healing
Risk factors
Overall
< 8 weeks
≥ 8 weeks
Ulcer size
Lesion site
Pathology of lesion
Duration of operation
t value-1.06-0.46-2.212.050.717.873.03
P value0.3110.6610.0780.0740.5200.0800.203
DISCUSSION

This systematic review and meta-analysis incorporated findings from 12 studies concerning ulcer healing rates and the risk factors associated with delayed healing following ESD. The findings indicated that there was no statistically significant difference in the rates of ulcer healing over an 8-week period; however, a statistically significant difference was observed over 8 weeks. Of the six risk factors examined, H. pylori infection, ulcer size, lesion site, and the pathological characteristics of the lesion were linked to a prolonged healing process of the ulcer., while diabetes and duration of operation were not.

As the mucosal defect after ESD often reaches the submucosal layer, the resulting artificial ulcers are considered similar to peptic ulcers. The healing process of these ulcers is classified into phases A, H, and S, referencing the criteria for peptic ulcers[18]. Nevertheless, the ideal duration of treatment for ulcers induced by ESD remains undetermined. Most ulcers achieve complete healing within 4-8 weeks[29,30]. Park et al[31] proposed that a treatment duration of 4 weeks is adequate for the management of ulcers induced by ESD, as there was no significant difference observed in the healing of ulcers between 4-weeks and 8-weeks treatment periods. A prospective multicenter observational study demonstrated that both six-week and eight-week intervals were equally effective in promoting the healing of artificial ulcers following ESD[32]. However, 5%-20% of patients with post-ESD ulcers did not heal after more than eight weeks. Kakushima et al[8] reported that eight weeks of treatment were necessary for ESD-induced macroscopic ulcers, as four weeks of proton pump inhibitor treatment were insufficient[8,18,23]. The absence of a well-defined criterion could be the cause of these contentious outcomes. Potential affecting factors include pathology, lesion site, size, and H. pylori infection. The findings from the meta-analysis indicate a notable enhancement in the healing rate of ulcers over 8 weeks, as well as a statistically significant difference between the healing rate during this timeframe and the rate of non-healing. This suggests that extending the treatment of post-ESD ulcer patients to more than 8 weeks contributes to the complete healing of postoperative ulcerations of ESD.

Infection with H. pylori has been associated with the healing process of peptic ulcers. Nevertheless, there remains a contentious discussion regarding the influence of H. pylori infection on the healing of ulcers induced by medical interventions. Several studies have indicated that the eradication of H. pylori facilitates the healing process of ulcers[2,33]. Conversely, a multi-center trial has proposed that H. pylori infection does not influence the healing of ulcers following ESD[10,34]. Chronic infection with H. pylori was not found to be associated with a prolonged healing process of ulcers[9]. According to this meta-analysis, H. pylori infection is a risk factor for ulcers following ESD, and its eradication aids in ulcer healing. H. pylori eradication may improve inflammation and atrophy of the mucosa and promote ulcer recovery, however, further investigation is required to substantiate these claims.

In the present investigation concerning the determinants influencing the healing of stomach ulcers following ESD, most of the research suggests that the size of the ulcer serves as an independent risk factor[1,16,35]. Post-ESD ulcer healing is similar to peptic ulcers, with a larger area of mucous membrane defect prolonging the mucosal reconstruction process[25]. The findings of this meta-analysis further corroborate this conclusion. However, the included studies may have a publication bias, suggesting that negative results are difficult to publish. Further investigation is required to ascertain the validity of these results. The meta-analysis revealed the presence of heterogeneity, which may be due to differences in research methods, design, ulcer evaluation criteria, and sample size, requiring more randomized studies for validation.

Kobayashi et al[18] found that antral lesions exhibited a superior marginal healing rate compared to lesions located in the body of the stomach. Additionally, a multi-center randomized study indicated that the anatomical positioning of gastric tumors, specifically in the upper and middle thirds of the stomach, may have a comparable effect on the healing process of ulcers resulting from ESD when contrasted with those located in the lower third. However, some studies indicates that the positioning of the lesion within the lower third of the stomach serves as an independent risk factor for the delayed healing of ulcers following ESD[16,25,36], which was supported by our meta-analysis. The differences in findings may be related to inconsistencies in multifactor regression analysis adjustment and ulcer cure criteria.

Although the three included studies suggested that ulcer healing was not related to the pathological type of the ulcer, our meta-analysis indicates that ulcer pathology does affect healing. Chang et al[37] identified that histologically confirmed high-grade dysplasia or early-stage gastric cancer serve as independent risk factors for the delayed healing of ulcers following ESD. Early-stage stomach cancer, particularly when the degree of differentiation is high, is more likely to delay healing, which may be linked to the depth and extent of infiltration[38]. However, owing to the restricted volume of literature included, it is not feasible to conduct further subgroup analyses, thereby necessitating additional research.

Lim et al[9] identified that diabetes mellitus serves as an independent risk factor for the delayed healing of ulcers following ESD. However, the findings of this meta-analysis indicate that diabetes does not constitute a significant risk factor for the delayed healing of ulcers. The differences in results may be due to varying study designs and sample sizes, as well as the lack of specific details on blood sugar control and the duration of diabetes in the included articles. Since only two studies were included, the reliability of this conclusion needs to be confirmed by further research.

Despite ongoing debate regarding the impact of procedure duration on the healing of ulcers, long ESD operations may affect ulcer healing due to an increased risk of musculoskeletal damage or bleeding[24,25]. However, our meta-analysis suggests that procedure duration does not affect ulcer healing.

The findings of this meta-analysis may offer valuable insights for the personalized treatment and management of endoscopic removal ulcers within clinical settings, but several limitations exist: Firstly, the results were based on observational studies. Although we strictly defined the outcome indicators and included results of multi-factor analysis, the details of potentially mixed factors remain unclear due to the inherent bias risk in observational descriptive studies. Secondly, individual risk factors were included in fewer studies, preventing subgroup analysis, which may impact the meta-analysis results. Thirdly, the risk factors included in each study varied, and the same risk factor was stratified differently. Factors such as musculoskeletal damage, mucous membrane shrinkage, bleeding, and drug effects were studied less frequently and could not undergo meta-analysis. Finally, individual risk factors demonstrate evidence of publication bias, which could potentially undermine the reliability of the results. Consequently, it is imperative to conduct high-quality studies to validate our findings.

CONCLUSION

The findings of our meta-analysis indicate a notable enhancement in the healing rate of ulcers over an eight-week period. Prolonging the treatment duration for patients with post-ESD ulcers beyond eight weeks is associated with improved outcomes in the complete resolution of postoperative ulcerations resulting from ESD. Furthermore, factors such as H. pylori infection, ulcer size, lesion location, and the pathological characteristics of the lesion have been identified as significant risk factors contributing to delayed ulcer healing. More large-sample, high-quality research is needed to further validate these risk factors for delayed post-ESD ulcers.

ACKNOWLEDGEMENTS

Huang FX provided guidance in the prospective register of systematic reviews.

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country of origin: China

Peer-review report’s classification

Scientific Quality: Grade B

Novelty: Grade B

Creativity or Innovation: Grade B

Scientific Significance: Grade B

P-Reviewer: Li S S-Editor: Fan M L-Editor: A P-Editor: Wang WB

References
1.  Oh TH, Jung HY, Choi KD, Lee GH, Song HJ, Choi KS, Chung JW, Byeon JS, Myung SJ, Yang SK, Kim JH. Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks. Dig Dis Sci. 2009;54:1494-1499.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 32]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
2.  Song WC, Wang XF, Lv WW, Xu XY, Tian M. The effect of early Helicobacter pylori eradication on the healing of ESD-induced artificial ulcers: A retrospective study. Medicine (Baltimore). 2019;98:e15807.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
3.  Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225-229.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1134]  [Cited by in F6Publishing: 1124]  [Article Influence: 48.9]  [Reference Citation Analysis (4)]
4.  Ono H, Yao K, Fujishiro M, Oda I, Uedo N, Nimura S, Yahagi N, Iishi H, Oka M, Ajioka Y, Fujimoto K. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33:4-20.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 137]  [Cited by in F6Publishing: 248]  [Article Influence: 82.7]  [Reference Citation Analysis (0)]
5.  Kawano S, Okada H, Kawahara Y, Hori K, Tanioka D, Tsuzuki T, Inoue M, Yagi S, Takenaka R, Yamamoto K. Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial. Digestion. 2011;84:46-53.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 25]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
6.  Horikawa Y, Mimori N, Mizutamari H, Kato Y, Shimazu K, Sawaguchi M, Tawaraya S, Igarashi K, Okubo S. Proper muscle layer damage affects ulcer healing after gastric endoscopic submucosal dissection. Dig Endosc. 2015;27:747-753.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 11]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
7.  Kakushima N, Yahagi N, Fujishiro M, Iguchi M, Oka M, Kobayashi K, Hashimoto T, Omata M. The healing process of gastric artificial ulcers after endoscopic submucosal dissection. Digest Endosc. 2004;16:327-331.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 83]  [Cited by in F6Publishing: 85]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
8.  Kakushima N, Fujishiro M, Kodashima S, Kobayashi K, Tateishi A, Iguchi M, Imagawa A, Motoi T, Yahagi N, Omata M. Histopathologic characteristics of gastric ulcers created by endoscopic submucosal dissection. Endoscopy. 2006;38:412-415.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 62]  [Cited by in F6Publishing: 65]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
9.  Lim JH, Kim SG, Choi J, Im JP, Kim JS, Jung HC. Risk factors of delayed ulcer healing after gastric endoscopic submucosal dissection. Surg Endosc. 2015;29:3666-3673.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 25]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
10.  Yoshizawa Y, Sugimoto M, Sato Y, Sahara S, Ichikawa H, Kagami T, Hosoda Y, Kimata M, Tamura S, Kobayashi Y, Osawa S, Sugimoto K, Miyajima H, Furuta T. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial. Dig Endosc. 2016;28:162-172.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 19]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
11.  Takeuchi N, Umegaki E, Takeuchi T, Murano Yukiko Yoda M, Tokioka S, Higuchi K. Gastric ulcer healing after treatment of endoscopic submucosal dissection in Japanese: comparison of H(2) receptor antagonist and proton pump inhibitor administration. J Clin Biochem Nutr. 2011;49:216-221.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
12.  . ENDO 2017 Poster Presentations. Dig Endosc. 2017;29 Suppl 1:29-261.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
13.  Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32381]  [Cited by in F6Publishing: 28484]  [Article Influence: 9494.7]  [Reference Citation Analysis (0)]
14.  Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14425]  [Cited by in F6Publishing: 16122]  [Article Influence: 671.8]  [Reference Citation Analysis (0)]
15.  Wells GA, Wells G, Shea B, O'Connell D, Peterson J, Welch V, Tugwell P.   The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa Hospital Research Institute, 2014. Available from: https://www.ohri.ca/programs/clinical epidemiology/oxford.asp.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Nakamura K, Ihara E, Akiho H, Akahoshi K, Harada N, Ochiai T, Nakamura N, Ogino H, Iwasa T, Aso A, Iboshi Y, Takayanagi R. Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy. Gut Liver. 2016;10:917-924.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 15]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
17.  Kato T, Araki H, Onogi F, Ibuka T, Sugiyama A, Tomita E, Nagaki M, Moriwaki H. Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study. J Gastroenterol. 2010;45:285-290.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 46]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
18.  Kobayashi M, Takeuchi M, Hashimoto S, Mizuno K, Sato Y, Narisawa R, Aoyagi Y. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide. Dig Dis Sci. 2012;57:119-126.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 37]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
19.  Park JH, Baek EK, Choi CH, Lee KH, Kim BJ, Kim JW, Kim JG, Chang SK. Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study. Surg Endosc. 2014;28:235-241.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 11]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
20.  Gong SD, Li H, Xie YB, Wang XH. Construction and analysis of an ulcer risk prediction model after endoscopic submucosal dissection for early gastric cancer. World J Gastrointest Oncol. 2022;14:1823-1832.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
21.  Fei HH, Qian DX, Xing YF, Zhao J. [Risk factors associated with ulcer healing after endoscopic mucosal dissection for gastric mucosal lesions]. Jiankang Zhiyou. 2021;6:76.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Huang JM, He LP. [Analysis of factors affecting ulcer healing after endoscopic submucosal dissection for early gastric cancer]. Linchuang Heli Yongyao Zazhi. 2017;29:11-12.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Lee SH, Lee CK, Chung IK, Shim YS, Lee TH, Lee SH, Kim HS, Park SH, Kim SJ. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study. Dig Dis Sci. 2012;57:429-434.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 28]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
24.  Otsuka T, Sugimoto M, Ban H, Nakata T, Murata M, Nishida A, Inatomi O, Bamba S, Andoh A. Severity of gastric mucosal atrophy affects the healing speed of post-endoscopic submucosal dissection ulcers. World J Gastrointest Endosc. 2018;10:83-92.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 10]  [Cited by in F6Publishing: 9]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
25.  Shimozato A, Sasaki M, Ogasawara N, Funaki Y, Ebi M, Tamura Y, Izawa S, Hijikata Y, Yamaguchi Y, Kasugai K. Risk Factors for Delayed Ulcer Healing after Endoscopic Submucosal Dissection of Gastric Neoplasms. J Gastrointestin Liver Dis. 2017;26:363-368.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 15]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
26.  Shen SY, Jiang WJ, Ruan KX, Li YJ. [Analysis of factors affecting ulcer healing after gastric ESD]. Nongken Yixue. 2016;28:512-514.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Shao XN, Shen JW, Shen RW, Chen DW, Lu T, Chu X. [Analysis of factors affecting ulcer healing after endoscopic gastric mucosal dissection]. Zhejiang Linchuang Yixue. 2020;22:49-50.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Yamasaki A, Yoshio T, Muramatsu Y, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Sasaki Y, Fujisaki J. Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers. Digestion. 2018;97:170-176.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 19]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
29.  Imaeda H, Hosoe N, Suzuki H, Saito Y, Ida Y, Nakamura R, Iwao Y, Ogata H, Hibi T. Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia. J Gastroenterol. 2011;46:1267-1272.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 27]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
30.  Cho EY, Yim HJ, Jung YK, Suh SJ, Seo YS, Kim JH, Kim HS, Lee SH, Ahn SH, Lee JI, Jeong SH, Kim JW, Lee JW, Kim IH, Kim HS, Park SJ, Lee JM, Hwang SG; Antiviral Resistance Study Group. Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study. Gut Liver. 2017;11:129-135.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 3]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
31.  Park HJ, Kim HS, Kim BR, Park SY, Hong JH, Jo KW, Kim JW. Half-dose rabeprazole has an equal efficacy to standard-dose rabeprazole on endoscopic submucosal dissection-induced ulcer. Dig Dis Sci. 2013;58:1054-1061.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
32.  Ishida T, Dohi O, Yamada S, Yasuda T, Yamada N, Tomie A, Tsuji T, Horii Y, Majima A, Horie R, Fukui A, Zen K, Tomatsuri N, Yagi N, Naito Y, Itoh Y. Clinical Outcomes of Vonoprazan-Treated Patients after Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Multicenter Observation Study. Digestion. 2021;102:386-396.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
33.  Micic D, Kendereski A, Popovic V, Manojlovic D, Micic J. Insulin sensitivity in patients with primary hyperparathyroidism before and after parathyroidectomy: sequential euglycemic insulin clamp studies. Horm Metab Res. 1991;23:288-289.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
34.  Kim SG, Song HJ, Choi IJ, Cho WY, Lee JH, Keum B, Lee YC, Kim JG, Park SK, Park BJ, Jung HC; Korean College of Helicobacter, Upper Gastrointestinal Research. Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial. Dig Liver Dis. 2013;45:385-389.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
35.  Ko J, Kim SJ, Kang DH, Choi CW, Kim HW, Park SB. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study. Medicine (Baltimore). 2019;98:e15701.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 4]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
36.  Uchida E, Kato S, Tsuchiya I, Ohkuma K, Taniguchi L, Tanida E, Masui Y, Yoshizawa K, Nakajima A, Izumi M. Percent reduction of the ulcer size at 4 weeks is a predictor of the complete healing of endoscopic submucosal dissection-induced gastric ulcers. Arab J Gastroenterol. 2020;21:183-188.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
37.  Chang YW, Jang JY, Kim JW, Ko WJ. Risk factors of delayed healing of iatrogenic gastric ulcer after endoscopic resection. Conference Abstract. UEG Week 2013 Poster Presentations. United Eur Gastroent. 2013;1:A135-A587.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 9]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
38.  Horiuchi Y, Fujisaki J, Yamamoto N, Ishizuka N, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T. Undifferentiated-type predominant mixed-type early gastric cancer is a significant risk factor for requiring additional surgeries after endoscopic submucosal dissection. Sci Rep. 2020;10:6748.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 9]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]